Literature DB >> 7708730

Endogenously opsonized particles divert prostanoid action from lethal to protective in models of experimental endotoxemia.

D F Eierman1, M Yagami, S M Erme, S R Minchey, P A Harmon, K J Pratt, A S Janoff.   

Abstract

We report that, in rats, the lethal consequences of high-dose endotoxin challenge are exacerbated by the intravascular administration of prostaglandin E1 but attenuated by the intravascular administration of endocytosable particles. This protection is mediated by opsonins. Nonopsonizable particles were unable to provide protection unless first pseudoopsonized with antibody directed against the CR3 (CD11b/CD18) phagocyte receptor. We show that endogenously opsonized particles can act in concert with prostaglandin E1 (putatively by elevation of neutrophil intracellular cAMP and the resultant downregulation of CR3) to completely rescue animals from the lethal late-stage sequelae of experimental endotoxemia. These data illustrate that the interaction of particles with cellular receptors can transform the overall systemic response to prostaglandin E1 from pro- to antiinflammatory. This suggests a role for multiple receptor engagement events in defining the systemic prostaglandin response and offers a rationale for developing new therapeutic modalities in the treatment of sepsis and other inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7708730      PMCID: PMC42309          DOI: 10.1073/pnas.92.7.2815

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Involvement of multiple kinases in neutrophil activation.

Authors:  D J Lu; W Furuya; S Grinstein
Journal:  Blood Cells       Date:  1993

2.  Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors.

Authors:  A Novogrodsky; A Vanichkin; M Patya; A Gazit; N Osherov; A Levitzki
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

3.  The cooperative effects of TNF-alpha and IFN-gamma are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia.

Authors:  S R Smith; C Terminelli; L Kenworthy-Bott; A Calzetta; J Donkin
Journal:  J Leukoc Biol       Date:  1994-06       Impact factor: 4.962

4.  Signaling properties of CR3 (CD11b/CD18) and CR1 (CD35) in relation to phagocytosis of complement-opsonized particles.

Authors:  M Fällman; R Andersson; T Andersson
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

5.  Increasing cAMP attenuates activation of mitogen-activated protein kinase.

Authors:  B R Sevetson; X Kong; J C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

Review 6.  Use of novel therapeutic agents for the treatment of serious infection.

Authors:  D L Dunn
Journal:  Am J Surg       Date:  1993-11       Impact factor: 2.565

7.  Liposome-complement interactions in rat serum: implications for liposome survival studies.

Authors:  D V Devine; K Wong; K Serrano; A Chonn; P R Cullis
Journal:  Biochim Biophys Acta       Date:  1994-04-20

8.  The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

Authors:  B N Cronstein; D Naime; E Ostad
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 9.  The determination of liposome captured volume.

Authors:  W R Perkins; S R Minchey; P L Ahl; A S Janoff
Journal:  Chem Phys Lipids       Date:  1993-09       Impact factor: 3.329

10.  Beta 2 integrin engagement triggers actin polymerization and phosphatidylinositol trisphosphate formation in non-adherent human neutrophils.

Authors:  R Löfgren; J Ng-Sikorski; A Sjölander; T Andersson
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

View more
  7 in total

1.  The clinical practice guideline for the management of ARDS in Japan.

Authors:  Satoru Hashimoto; Masamitsu Sanui; Moritoki Egi; Shinichiro Ohshimo; Junji Shiotsuka; Ryutaro Seo; Ryoma Tanaka; Yu Tanaka; Yasuhiro Norisue; Yoshiro Hayashi; Eishu Nango
Journal:  J Intensive Care       Date:  2017-07-25

2.  Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice.

Authors:  Russell E Lewis; Georgios Chamilos; Randall A Prince; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

3.  Passive transfer of poly-(1-6)-beta-glucotriosyl-(1-3)-beta-glucopyranose glucan protection against lethal infection in an animal model of intra-abdominal sepsis.

Authors:  R L Cisneros; F C Gibson; A O Tzianabos
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

Review 4.  Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.

Authors:  Magda Cepkova; Michael A Matthay
Journal:  J Intensive Care Med       Date:  2006 May-Jun       Impact factor: 3.510

5.  Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis.

Authors:  Hsin-Yun Sun; Barbara D Alexander; Olivier Lortholary; Francoise Dromer; Graeme N Forrest; G Marshall Lyon; Jyoti Somani; Krishan L Gupta; Ramon del Busto; Timothy L Pruett; Costi D Sifri; Ajit P Limaye; George T John; Goran B Klintmalm; Kenneth Pursell; Valentina Stosor; Michelle I Morris; Lorraine A Dowdy; Patricia Munoz; Andre C Kalil; Julia Garcia-Diaz; Susan Orloff; Andrew A House; Sally Houston; Dannah Wray; Shirish Huprikar; Leonard B Johnson; Atul Humar; Raymund R Razonable; Shahid Husain; Nina Singh
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

6.  Prolonging the in vivo residence time of prostaglandin E(1) with biodegradable nanoparticles.

Authors:  Tsutomu Ishihara; Miyuki Takahashi; Megumu Higaki; Mitsuko Takenaga; Tohru Mizushima; Yutaka Mizushima
Journal:  Pharm Res       Date:  2008-02-22       Impact factor: 4.200

Review 7.  Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B.

Authors:  Jill Adler-Moore; Russell E Lewis; Roger J M Brüggemann; Bart J A Rijnders; Andreas H Groll; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2019-05-02       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.